Skip to main content

Table 1 Trend in HIV seroprevalence among male patients with anal disease or with nonanal disease, 2007 - 2011

From: Hospital-based HIV/HSV-2 seroprevalence among male patients with anal disease in Korea: cross sectional study

Year

With anal diseases

With nonanal diseases

 

N (%)a

HIV +b

HIV seroprevalence per 10,000

N (%)a

HIV +b

HIV seroprevalence per 10,000

2007

23,861 (58.0)

24

10.1

17,274 (42.0)

0

0

2008

22,581 (54.3)

30

13.3

18,986 (45.7)

1

0.5

2009

26,173 (53.2)

20

7.6

23,000 (46.8)

0

0

2010

27,552 (56.3)

19

6.9

21,378 (43.7)

2

0.9

2011

30,225 (56.4)

23

7.6

23,382 (43.6)

0

0

  1. HIV prevalence was defined as the number of confirmed HIV cases per 10,000 HIV-tested people over a 1-year period.
  2. Nonanal diseases: patients who presented at the hospital with a nonanal disease or for a health checkup.
  3. aN (%): the number of individuals tested for HIV (the proportion of patients with anal disease or nonanal disease).
  4. bHIV+: the number of HIV-infected individuals.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us